BEACON THERAPEUTICS Trademark

Trademark Overview


On Monday, October 30, 2023, a trademark application was filed for BEACON THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the BEACON THERAPEUTICS trademark a serial number of 98247335. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Monday, September 16, 2024. This trademark is owned by Beacon Therapeutics Limited. The BEACON THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations and substances for the treatment of ocular disorders; biotechnological preparations for the treatment of ocular disorders; preparations for gene therapy and cell therapy for the treatment of ocular disorders; genetic medicines for the treatment of ocular disorders, all of foregoing available only by prescription from, and administration to patients by, clinical and medical professionals, and expressly excluding medical, devices, medical implants and medical apparatus and instruments of any kind

Research and development services and clinical trials services in the fields of in relation to pharmaceutical preparations and substances for the treatment of disorders relating to the eye, biotechnological preparations for the treatment of disorders relating to the eye, preparations for gene therapy and cell therapy for the treatment of disorders relating to the eye and genetic medicines for the treatment of disorders relating to the eye; consulting services for others in the field of design planning and implementation project management of clinical trials in the fields of pharmaceutical preparations and substances for the treatment of disorders relating to the eye, biotechnological preparations for the treatment of disorders relating to the eye, preparations for gene therapy and cell therapy for the treatment of disorders relating to the eye and genetic medicines for the treatment of disorders relating to the eye; scientific research in the nature of conducting clinical trials for ot...
beacon therapeutics

General Information


Serial Number98247335
Word MarkBEACON THERAPEUTICS
Filing DateMonday, October 30, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateMonday, September 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the stylized blue text 'BEACON" above the stylized blue text "THERAPEUTICS". The letter "O" in the word "BEACONE" is replaced by a circle design made up of six inward-pointing blue triangles.
Goods and ServicesPharmaceutical preparations and substances for the treatment of ocular disorders; biotechnological preparations for the treatment of ocular disorders; preparations for gene therapy and cell therapy for the treatment of ocular disorders; genetic medicines for the treatment of ocular disorders, all of foregoing available only by prescription from, and administration to patients by, clinical and medical professionals, and expressly excluding medical, devices, medical implants and medical apparatus and instruments of any kind
Indication of Colors claimedThe color(s) blue is/are claimed as a feature of the mark.
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesResearch and development services and clinical trials services in the fields of in relation to pharmaceutical preparations and substances for the treatment of disorders relating to the eye, biotechnological preparations for the treatment of disorders relating to the eye, preparations for gene therapy and cell therapy for the treatment of disorders relating to the eye and genetic medicines for the treatment of disorders relating to the eye; consulting services for others in the field of design planning and implementation project management of clinical trials in the fields of pharmaceutical preparations and substances for the treatment of disorders relating to the eye, biotechnological preparations for the treatment of disorders relating to the eye, preparations for gene therapy and cell therapy for the treatment of disorders relating to the eye and genetic medicines for the treatment of disorders relating to the eye; scientific research in the nature of conducting clinical trials for others in the fields of pharmaceutical preparations and substances for the treatment of disorders relating to the eye, biotechnological preparations for the treatment of disorders relating to the eye, preparations for gene therapy and cell therapy for the treatment of disorders relating to the eye and genetic medicines for the treatment of disorders relating to the eye

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 8, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 8, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBeacon Therapeutics Limited
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
AddressLondon N79AS

Trademark Events


Event DateEvent Description
Thursday, November 2, 2023NEW APPLICATION ENTERED
Wednesday, November 8, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 11, 2024ASSIGNED TO EXAMINER
Saturday, June 15, 2024NON-FINAL ACTION E-MAILED
Saturday, June 15, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, June 15, 2024NON-FINAL ACTION WRITTEN
Monday, September 16, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 16, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 16, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED